Tag Archives: Pfizer

Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …

New York, U.S. | Xinhua | Omicron was officially announced on Tuesday as the absolutely dominant variant of COVID-19 in the United States, as the country is entering the third year of the pandemic, with more curing pills ordered from Pfizer while the federal government’s policies criticized as murky. OMICRON DOMINANCE …

Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …

The Hague, Netherlands | Xinhua | The European Medicines Agency (EMA) on Thursday issued advice on the emergency use of Pfizer’s COVID-19 pill called Paxlovid. The European Union (EU) drug regulator said the medicine, which is not yet authorized in the EU, can be used to treat adults with COVID-19 who …

New York, U.S. | Xinhua | U.S. pharmaceutical giant Pfizer Inc. Tuesday said final results show that its novel COVID-19 oral antiviral tablets could reduce risk of hospitalization or death by close to 90 percent for high-risk patients. The results, based on an analysis of over 2,000 patients in a phase …

New York, U.S. | Xinhua | A booster shot of COVID-19 vaccine would provide enough protection against the Omicron variant while two doses may not be sufficient, said COVID-19 vaccine developers Pfizer Inc. and BioNTech SE on Wednesday. Three doses of the Pfizer-BioNTech COVID-19 vaccine would generate sufficient serum antibodies to …

Washington, U.S. | Xinhua | U.S. President Joe Biden on Monday sought to reassure the country about the new Omicron variant of the coronavirus, telling Americans that his administration was working with vaccine manufacturers to modify vaccines and booster shots should that prove necessary. “We’re throwing everything we have at this …

Washington, U.S. | Xinhua | U.S. multinational pharmaceutical and biotechnology corporation Pfizer has been bullying governments around the world in COVID-19 vaccine contracts, said a recent report. “The contracts offer a rare glimpse into the power one pharmaceutical corporation has gained to silence governments, throttle supply, shift risk and maximize profits …

New York, U.S. | Xinhua | Drugmakers Pfizer and BioNTech said on Tuesday that they had asked the U.S. Food and Drug Administration (FDA) to authorize booster shots of their COVID-19 vaccine for all adults 18 years old and over, seeking to broaden who is eligible for a third shot. The …

Berlin, Germany | Xinhua | A booster vaccination with the COVID-19 vaccine of BioNTech and Pfizer increased protection to up to 95.6 percent, the companies announced on Thursday. A randomized, controlled phase III study of more than 10,000 people aged 16 years and older found that booster vaccinations with the Comirnaty …